Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Deborah.Kan
Building a Bridge Between Patients and Alzheimer’s Treatment Decision-Makers
LuPita Gutierrez-Parker: On Life and Advocacy with Early-Onset Dementia
NEW INTERACTIVE GUIDE: The Science of Alzheimer’s
‘Don’t Let Doctors Dismiss Your Concerns:’ A Neurologist on Diagnosing Dementia
Digging In to Dementia Misdiagnosis
Is It Alzheimer’s or Another Type of Dementia? How Doctors Make a Diagnosis
Panel: Fighting Dementia in Black Communities Through Education
Research Underway: Dance As Dementia Therapy
The Pain of Being Misdiagnosed: Early-Onset Alzheimer’s vs. Lewy Body Dementia
Dementia & Driving: How Do You Know When It’s Time to Hand Over the Keys?
Panel: Bringing Brain Health Equity to Communities of Color
Laurie Scherrer’s Top 4 Rules for Better Living With Dementia
Alzheimer’s Drug Trial Process Has an Abysmal Failure Rate. VR Could Change That
A Nutritionist Digs In to Turmeric and Curcumin for Brain Health
At AAIC, We Tracked Down Answers to Readers’ Alzheimer’s Drug Questions
Previous
7
8
9
Next
Page load link
Go to Top